Molecular genetic studies of schizophrenia

Brain Research Reviews

Volumn 31, Issue 2-3, 2000, Pages 179-186

  Owen, Michael J ^a  

^a U   (United Kingdom)

Author keywords

Association; Genetics; Heritability; Linkage; Schizophrenia

Indexed keywords

DOPAMINE 3 RECEPTOR; SEROTONIN 2A RECEPTOR;

ANIMAL MODEL; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; GENETIC LINKAGE; HERITABILITY; HUMAN; INHERITANCE; MOLECULAR GENETICS; MUTATION; NONHUMAN; PRIORITY JOURNAL; SCHIZOPHRENIA;

ANIMALS; HUMANS; MOLECULAR BIOLOGY; SCHIZOPHRENIA;

EID: 0034010513     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(99)00035-1     Document Type: Conference Paper

References (78)

1. Asherson P., Walsh C., Williams J., Sargeant M., Taylor C., Clements A., Gill M., Owen M., McGuffin P. Imprinting and Anticipation. Are they relevant to genetic studies of schizophrenia? Br. J. Psychiatry. 164:1994;619-624.
2. Asherson P., Mant R., Holmans P., Williams J., Cardno A., Murphy K., Jones L., Collier D., McGuffin P., Owen M.J. Linkage, association and mutation analysis at the dopamine D3 receptor gene in schizophrenia. Mol. Psychiatry. 1:1996;125-132.
3. Barcellos L.F., Klitz W., Field L., Tobias R., Bowcock A.M., Wilson R., Nelson M.P. Association mapping of disease loci by use of a pooled DNA genomic screen. Am. J. Hum. Genet. 61:1997;734-747.
4. Bassett A.S., Honer W.G. Evidence for anticipation in schizophrenia. Am. J. Hum. Genet. 54:1994;864-870.
5. Bennett S.T., Lucassen A.M., Gough S.C.L., Powell E.E., Undlien D.E., Pritchard L.E., Merriman M.E., Kawaguchi Y., Dronsfield M.J., Pociot F., Nerup J., Bouzekri N., Cambonthomsen A., Ronningen K.S., Barnett A.H., Bain S.C., Todd J.A. Susceptibility to human type-1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locusy. Nat. Genet. 9:1995;284-292.
6. Berrettini W.H., Ferraro T.N., Alexander R.C., Buchberg A.M., Vogel W.H. Quantitative trait loci mapping of three loci controlling morphine preference using inbred mouse strains. Nat. Genet. 7:1994;54-58.
7. Blouin J.L., Dombroski B.A., Nath S.K., Lasseter V.K., Woyniec P.S., Nestadt G., Thorniquist M., Ullrich G., McGrath J., Kasch L., Lamacz M., Thomas M.G., Gehrig C., Radhakrishna U., Snyder S.E., Balk K.G., Neufeld K., Swartz K.L., DeMarchi N., Papadimitriou G.N., Dikeos D.G., Stefanis C.N., Chakravarti A., Childs B., Housman D.E., Kazazian H.H., Antonarakis S.E., Pulver A.E. Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nat. Genet. 20:1998;1061-4036.
8. Breschel T.S., McInnis M.G., Margolis R.L., Sirugo G., Corneliussen B., Simpson S.G., McMahon F., MacKinnon D.F., Xu J.F., Pleasant N., Huo Y., Ashworth R.G., Grundstorm C., Grundstorm T., Kidd J.J., DePaulo J.R., Ross C.A. A novel, heritable, expanding CTG repeat in an intron of the SEF2-1 gene on chromosome 18q21.1. Hum. Mol. Genet. 6:1997;1855-1863.
9. Brook J.D., McCurrach M.E., Harley H.G., Buckler A.J., Church D., Aburatani H., Hunter K., Stanton V.P., Thirion J.P., Hudson T., Sohn R., Zemelman B., Snell R.T., Rundle S.A., Crow S., Davies J., Shelbourne P., Buxton J., Jones C., Juvonen C., Johnson K., Harper P.S., Shaw D.J., Housman D.E. Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell. 8:1992;799.
10. Collins F.S., Guyer M.S., Chakravarti A. Variations on a theme. Cataloging human DNA sequence variation. Science. 278:1997;1580-1581.
11. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericakvance M.A. Gene dose of apolipoprotein E type-4 allele and the risk of Alzheimer's disease in late-onset families. Science. 261:1993;921-923.
12. Craddock N., Khodel V., Van Eerdewegh P., Reich T. Mathematical limits of multilocus models: the genetic transmission of bipolar disorder. Am. J. Hum. Genet. 57:1995;690-702.
13. Crocq M.A., Mant R., Asherson P., Williams J., Hode Y., Mayerova A., Collier D., Lannfelt L., Sokoloff P., Schwartz J.C., Gill M., Macher J.P., McGuffin P., Owen M.J. Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J. Med. Gen. 29:1992;858-860.
14. Daniels J., Holmans P., Williams N., Turic D., McGuffin P., Plomin R., Owen M.J. A simple method for analysing microsatellite allele image patterns generated from DNA pools and its application to allelic association studies. Am. J. Hum. Genet. 62:1998;1189-1197.
15. Egger M., Davey Smith G. Misleading meta-analysis. Br. Med. J. 310:1995;752-754.
16. Faraone S.V., Matise T., Svrakic D., Pepple J., Malaspina D., Suarez B., Hampe C., Zambutto C.T., Schmitt J., Meyer J., Markel P., Lee H., Harkavyfriedman J., Kaufmann C., Cloninger C.R., Tsuang M.T. Genome scan of European-American schizophrenia pedigrees. Results of the NIMH Genetics Initiative and Millenium Consortium. Am. J. Med. Genet. 81:1998;290-295.
17. Flint J. Freeze! Nat. Genet. 17:1997;250-251.
18. Flint J., Corley R. Do animal-models have a place in the genetic analysis of quantitative human behavioural traits. J. Mol. Med. 74:1996;515-521.
19. Flint J., Corley R., DeFries J.C., Fulker D.W., Gray J.A., Miller S., Collins A.C. A simple genetic-basis for a complex psychological trait in laboratory mice. Science. 269:1995;1432-1435.
20. Goate A., Chartier-Harlin M.C., Mullan M.E. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 349:1991;704-706.
21. Hauser E.R., Boehnke M., Guo S.W., Risch N. Affected-sib-pair interval mapping and exclusion for complex genetic-traits - sampling considerations. Genet. Epidemiol. 13:1996;117-137.
22. F.A. Henn, E. Edwards, Animal models in the study of genetic factors in human psychopathology, in: P. Papalos, H.M. Lachman (Eds.), Genetic Studies of Affective Disorders, Wiley, New York, 1994, p. 177.
23. Holmans P. Asymptomatic properties of affected sib-pair linkage analysis. Am. J. Hum. Genet. 52:1993;362-374.
24. Holmans P., Craddock N. Efficient strategies for genome scanning using maximum likelihood affected sib-pair analysis. Am. J. Hum. Genet. 60:1997;657-666.
25. Ikeuchi T., Sanpei K., Takano H., Sasaki H., Tashiro K., Cancel G., Brice A., Bird T.D., Schellenberg G.D., Pericak Vance M.A., Welsh Bohmer K.A., Clark L.N., Wilhelmsen K., Tsuji S. A novel long and unstable CAG/CTG trinucleotide repeat on chromosome 17q. Genomics. 49:1998;321-326.
26. Julier C., Lucassen A., Villedieu P., Delepine M., Levymarchal C., Danze P.M., Bianchi F., Boitard C., Froguel P., Bell J. Multiple DNA variant association analysis - application to the insulin gene region in type-i diabetes. Am. J. Hum. Genet. 55:1994;1247-1254.
27. Karayiorgou M., Gogos J.A. A turning point in schizophrenia genetics. Neuron. 19:1997;967-979.
28. Kendler K.S., McGuire M., Gruenberg A.M. The Roscommon Family Study II. The risk of non-schizophrenic non-affective psychoses in relatives. Arch. Gen. Psychiatry. 50:1993;645-652.
29. Kendler K.S., McGuire M., Gruenberg A.M. The Roscommon Family Study III. Schizophrenia-related personality disorders in relatives. Arch. Gen. Psychiatry. 50:1993;781-788.
30. Kruglyak L. What is significant in whole-genome linkage disequilibrium studies? Am. J. Hum. Genet. 61:1997;810-812.
31. Lander E.S. The new genomics: Global view of biology. Science. 274:1996;536-539.
32. Lander E.S., Schork N.J. Genetic dissection of complex traits. Science. 264:1994;2037-2048.
33. Levy-Lahad E., Wasco W., Poorkaj P., Romano D.M., Oshima J., Pettingell W.H., Yu C.E., Jondro P.D., Schmidt S.D., Wang K. Candidate gene for the chromosome-1 familial Alzheimers-Disease locus. Science. 269:1995;973-977.
34. Lin M.W., Curtis D., Williams N., Arranz M., Nanko S., Collier D., McGuffin P., Murray R., Owen M., Gill M., Powell J.F. Suggestive evidence for linkage of schizophrenia to markers on chromosome 13q14.1-q22. Psychiat. Genet. 5:1995;117-126.
35. Mant R., Williams J., Asherson P.W., Parfitt E., McGuffin P., Owen M.J. The relationship between homozygosity at the dopamine D3 receptor gene and schizophrenia. Am. J. Med. Genet.: Neuropsych. Genet. 54:1994;21-26.
36. McGue M., Gottesman I.I. Genetic linkage and schizophrenia, perspectives from genetic epidemiology. Schizophr. Bull. 15:1989;453-464.
37. McGuffin P., Owen M.J. Molecular genetic studies of schizophrenia. Cold Spring Harbor Symp. Quant. Biol. 61:1996;815-822.
38. McGuffin P., Owen M.J., Farmer A.E. Genetic basis of schizophrenia. Lancet. 346:1995;678.
39. P. McGuffin, M.J. Owen, M.C. O'Donovan, A. Thapar, I. Gottesman, Seminars in Psychiatric Genetics, Gaskell, London, 1994.
40. Merriman T., Twells R., Merriman M., Eaves I., Cox R., Cucca F., McKinney P., Shield J., Baum D., Bosi E., Pozzilli P., Nistico L., Buzzetti R., Joner G., Ronningen K., Thorsby E., Undlien D., Pociot F., Nerup J., Bain S., Barnett A., Todd J. Evidence by allelic association-dependent methods for a type 1 diabetes polygene (IDDM6) on chromosome 18q21. Hum. Mol. Genet. 6:1997;1003-1010.
41. Moisan M.P., Courvoisier H., Bihoreau M.T., Gauguier D., Hendley E.D., Lathrop M., James M.R., Mormede P. A major quantitative trait locus influences hyperactivity in the wkha rat. Nat. Genet. 14:1996;471-473.
42. Moldin S.O. The maddening hunt for madness genes. Nat. Genet. 17:1997;127-129.
43. Moldin S.O., Gottesman I.I. At issue: Genes, experience, and chance in schizophrenia - Positioning for the 21st century. Schizophr. Bull. 23:1997;547-561.
44. Morris A.G., Gaitonde E., McKenna P.J., Mollon J.D., Hunt D.M. CAG repeat expansions and schizophrenia - association with disease in females and with early age at onset. Hum. Mol. Gen. 4:1995;1957-1961.
45. Murphy K.C., Owen M.J., Murphy K.C., Owen M.J. The behavioural phenotype in velo-cardio-facial syndrome. Am. J. Hum. Genet. 61(4 SS):1997;15.
46. O'Donovan M.C., Owen M.J. The molecular genetics of schizophrenia. Ann. Med. 28:1996;541-546.
47. O'Donovan M., Guy C., Craddock N., Bowen T., McKeon P., Macedo A., Maier W., Wildenauer D., Aschauer H.N., Sorbi S., Feldman E., Mynett-Johnson L., Claffey E., Nacimas B., Valente J., Dourado A., Grassi E., Lenzinger E., Heiden A.M., Moorhead S., O'Donovan C., Guy C., Craddock N., Murphy K.C., Cardno A.C., Jones L.A., Owen M.J., McGuffin P. Schizophrenia and bipolar disorder are associated with expanded CAG/CTG repeats. Nat. Genet. 10:1995;380-381.
48. Owen M.J., Holmans P., McGuffin P. Association studies in psychiatric genetics. Mol. Psychiatry. 2:1997;270-273.
49. Owen M.J., McGuffin P. Association and linkage - complementary strategies for complex disorders. J. Med. Genet. 30:1993;638-639.
50. Penrose L.S. Survey of cases of familial mental illness. Euro. Arch. Psych. Clin. Neuro. 240:1991;315-324.
51. Pericak-Vance M.A., Haines J.L., StGeorge-Hyslop P.H., Bebout J., Haynes C., Tanzi R., Yamaoka L., Gusella J.F., Roses A.D. Joint linkage analysis of chromosome-19 and chromosome-21 loci in familial alzheimer-disease. Am. J. Hum. Genet. 49:1991;355.
52. Plomin R., Owen M.J., McGuffin P. The genetic basis of complex human behaviours. Science. 264:1994;1733-1739.
53. Pulver A.E., Nestadt G., Goldberg R. Psychotic illness in patients diagnosed with velo-cardio-facial syndrome. Am. J. Med. Genet. 42:1992;141-142.
54. Risch N. Linkage strategies for genetically complex traits.1. multilocus models. Am. J. Hum. Gen. 46:1990;222-228.
55. Risch N., Merikangas K. The future of genetic-studies of complex human-diseases. Science. 273:1996;1516-1517.
56. Samani N.J., Thompson J.R., O'Toole L., Channer K., Woods K.L. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation. 94:1996;708-712.
57. Schizophrenia Collaborative Linkage Group A combined analysis of D22S278 marker alleles in affected sib-pairs: Support for a susceptibility locus for schizophrenia at chromosome 22q12. Am. J. Med. Genet.: Neuropsych. Genet. 67:1996;40-45.
58. Schizophrenia Linkage Collaborative Group for Chromosomes 3, 6, and 8 Additional support for schizophrenia linkage on chromosomes 6 and 8. A multicentre study. Am. J. Med. Genet. 67:1996;580-594.
59. Scott W., Pericak Vance M., Haines J. Genetic analysis of complex diseases. Science. 275:1997;1327.
60. Sherrington R., Brynjolfsson J., Petursson H. Localization of a susceptiblity locus for schizophrenia on chromosome 5. Nature. 336:1989;164-167.
61. Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 375:1995;754-760.
62. Schaid D.J., Sommer S.S. Comparison of statistics for candidate-gene association studies using cases and parents. Am. J. Hum. Genet. 55:1994;402-409.
63. Schwab S.G., Eckstein S.G., Hallmayer J., Lerer B., Albus M., Borrmann M., Lichtermann D., Ertl M.A., Maier W., Wildenauer D.B. Evidence suggestive of a locus on chromosome 5q31 contributing to susceptibility for schizophrenia in German and Israeli families by multipoint affected sib-pair linkage analysis. Mol. Psychiatry. 2:1997;156-160.
64. Schwab S.G., Hallmayer J., Lerer B., Albus M., Borrmann M., Honig S., Strauss M., Segman R., Lichtermann D., Knapp M., Trixler M., Maier W., Wildenauer D.B. Support for a chromosome 18p locus conferring susceptibility to functional psychoses in families with schizophrenia, by association and linkage analysis. Am. J. Hum. Genet. 63:1998;1139-1152.
65. Schwab S.G., Hallmayer J., Albus M., Lerer B., Hanses C., Kanyas K., Segman R., Borrmann M., Dreikorn B., Lichtermann D., Rietschel M., Trixler M., Maier W., Wilenauer D.B. A potential susceptibility locus on chromosome 10p14-p11 in 72 families with schizophrenia. Am. J. Med. Genet. 81:1998;528-529.
66. Skoultchi A.I., Puech A., Saint-Jore B., Funke B., Copeland N., Jenkins N., Pandita R., Carlson C., Sirotkin H., Kucherlapati R., Morrow B.E. Comparative mapping of the human and mouse VCFS/DGS syntenic region discloses the presence of a large internal rearrangement. Am. J. Hum. Genet. 61:1997;A296.
67. Spurlock G., Heils A., Holmans P., Williams J., D'Souza U.M., Cardno A., Murphy K.C., Jones L., Buckland P.R., McGuffin P., Lesch K.P., Owen M.J. A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter. Mol. Psychiatry. 3:1998;42-49.
68. Straub R.E., Maclean C.J., O'Neill F.A., Walsh D., Kendler K.S. Support for a possible schizophrenia vulnerability locus in region 5q22-31 in Irish families. Mol. Psychiatry. 2:1997;148-155.
69. Straub R.E., Maclean C.J., Martin R.B., Ma Y.L., Myakisnev M.V., Harriskerr C., Webb B.T., O'Neill F.A., Walsh D., Kendler K.S. A schizophrenia locus may be located in region 10p15-p11. Am. J. Med. Gen. 81:1998;296-301.
70. Templeton A.R. A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping of DNA sequencing. V. Analysis of case/control sampling designs. Alzheimer's disease and the apoprotein E locus. Genetics. 140:1995;402-409.
71. Thibaut F., Martinez M., Petit M., Jay M., Campion D. Further evidence for anticipation in schizophrenia. Psych. Res. 59:1995;25-33.
72. Wang D.G., Fan J.B., Siao C.J., Berno A., Young P., Sapolsky R., Ghandour G., Perkins N., Winchester E., Spencer J. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science. 280:1998;1077-1082.
73. Willems P.J. Dynamic mutations hit double figures. Nat. Gen. 8:1994;213-215.
74. J. Williams, P. McGuffin, M. Nothen, M.J. Owen, and the EMASS Collaborative Group, Meta-analysis of association between the 5 HT2a receptor T102C polymorphism and schizophrenia, Lancet 349 (1997) 1221.
75. Williams J., Spurlock G., Holmans P., Mant R., Murphy K., Jones L., Cardno A., Asherson P., Blackwood D., Muir W., Meszaros K., Aschauer H., Mallet J., Laurent C., Pekkarinen P., Seppala J., Stefanis C.N., Papadimitriou G.N., Macciardi F., Verga M., Pato C., Azevedo H., Crocq M-A., Gurling H., Kalsi G., Curtis D., McGuffin P., Owen M.J. A meta-analysis and transmission disequilibrium study of association between the dopamine D3 receptor gene and schizophrenia. Mol. Psychiatry. 3:1998;141-149.
76. Williams J., Spurlock G., McGuffin P., Mallet J., Nothen M.N., Gill M., Aschauer H., Nylander P.-O., Macciardi F., Owen M.J. Association between schizophrenia and the T102C polymorphism of 5-hydroxytryptamine type 2a receptor gene. Lancet. 347:1996;1294-1296.
77. Wood G.K., Tomasiewicz H., Rutishauser U., Magnuson T., Quirion R., Rochford J., Srivastava L.K. NCAM-180 knockout mice display increased lateral ventricle size and reduced prepulse inhibition of startle. Neuroreport. 9:1998;461-466.
78. Yaw J., Mylesworsley M., Hoff M., Holik J., Freedman R., Byerley W., Goon H. Anticipation in multiplex schizophrenia pedigrees. Psych. Gen. 6:1996;7-11.